Home > Insider Trading > Filing (0001127602-11-029181)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
318154	Amgen Inc	AMGN	Biological Products, (No Disgnostic Substances) (2836)	953540776

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1199306	Anna Richo	One Amgen Center Drive Thousand Oaks CA 91320-1799	Svp & Cco	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-11-08	1,500	$58.07	3,743	No	4	S	Indirect	The Nicholas A. Moore and Anna S. Richo Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	The Nicholas A. Moore and Anna S. Richo Family Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	36,849	Direct
Common Stock	2,130	Indirect	401(k) Plan

Footnotes

These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 843 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; 20,000 RSUs which fully vest on 10/28/2013; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
These shares include 1,306 shares of common stock acquired under the Company's Employee Stock Purchase Plan.
These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.